Drug Discovery Technologies Market Booming in 2018 and Predicted to Achieve Double Digit CAGR by 2023

Drug discovery is the process by which new medications are discovered. It uses vast array of technologies in the process. Drug discovery technologies are used for the research and the launch of new drugs. Increased use of therapeutics in various diseases has created the need for drug discovery. Recently, with the development of technology, many new types of techniques such as nanotechnology and RNA interference are being used for the purpose of drug discovery. This has created the opportunities for drug discovery technology manufacturers in the new segments. The increasing incidences of diseases, patent expiries, pathogen resistance to old drugs and fierce competition among drug manufacturers are the key factors, which would drive the growth of drug discovery technologies market during the analysis period. Furthermore, in order to earn additional margins, the pharmaceutical companies are in pursuit of blockbuster drugs, which has increased the demand for drug discovery technologies. Factors restraining the market growth are long duration of drug discovery process, high initial setup cost and presence of stringent regulatory environment.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-toc-and-sample/1480

The global drug discovery market is segmented on the basis of technology type, application and geography. The technology types considered in this report are high throughput screening, genomics, biochips, pharmacogenomics, bioanalytical instruments, bioinformatics, nanotechnology and others (RNAi, combinatorial chemistry). Based on end user, the global drug discovery market is classified into pharmaceutical companies, biopharmaceutical companies, biotech companies and research institutes. Geographically, the report is segmented into four regions viz., North America, Europe, Asia-Pacific and LAMEA. One of the strategies adopted by major market players is collaboration. For instance, in 2015, Myriad Genetics collaborated with Abbott Laboratories. The companies profiled in this report are Abbott Laboratories, Albany Molecular Research, Arqule, Bio-Rad Laboratories, Caliper Life Sciences, Celera Corp, Charles River Laboratories International, Evotec Ag, Gyros AbIncyte Corp and Thermo Fisher Scientific Inc.

Global Drug Discovery Technologies Market: Region-wise Outlook

Geographically, the global market for drug discovery technologies can be segmented into the regions of North America, Europe, Asia Pacific, and Rest of the World. Currently, North America is the most lucrative market due to high concentration of world’s leading pharmaceutical companies. The governments in North American countries such as the U.S. and Canada have also formulated encouraging policies for the investors to research and develop new drugs. The demand for drug discovery technologies in the region of North America also gains from high-income population, collectively promising healthy potential returns on investments due to high adoption rate of new technologies. Asia Pacific holds immense promise as a market for drug discovery technologies due to rising disposable incomes, favorable long-term government policies, and aggressive investment by pharmaceutical industry in the region, which has skilled labor at affordable cost.

Companies mentioned in the research report

Some of the key players in the global drug discovery technologies market are Abbott Laboratories, Inc., Affymetrix Inc., Agilent Technologies, Inc., Bayer Healthcare AG, GE Healthcare Ltd., Albany Molecular Research Inc., Arqule Inc., Astrazeneca plc, Novartis AG, Luminex Corporation, and Molecular Discovery Ltd. Many of the key players are partnering to develop sophisticated drug discovery technologies and discover novel drugs for various ailments.

Get More Information @ https://www.alliedmarketresearch.com/purchase-enquiry/1480

Table Of Content

Chapter: 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. TOP PLAYER POSITIONING/MARKET SHARE ANALYSIS, 2016
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. CURRENT DISRUPTIVE TECHNOLOGIES

Access Full Summery @ https://www.alliedmarketresearch.com/drug-discovery-technology-market

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.